Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer

Yildirim F., YURDAKUL A. S., Ozkaya S., AKDEMİR Ü. Ö., ÖZTÜRK C.

CLINICAL RESPIRATORY JOURNAL, cilt.11, sa.5, ss.602-611, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1111/crj.12391
  • Dergi Adı: CLINICAL RESPIRATORY JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.602-611
  • Anahtar Kelimeler: median tumor volume, non-small cell lung cancer, SUVmax, total lesion glycolysis, POSITRON-EMISSION-TOMOGRAPHY, METABOLIC TUMOR VOLUME, STANDARDIZED UPTAKE VALUE, MALIGNANT PLEURAL MESOTHELIOMA, FDG-PET/CT, RESPONSE EVALUATION, F-18-FDG PET/CT, RECTAL-CANCER, STAGE, SURVIVAL
  • Gazi Üniversitesi Adresli: Evet

Özet

Background and AimsTo determine whether the primary tumor SUVmax and total lesion glycolysis (TLG) measured on F-18-FDG PET/CT have prognostic significance in patients with non-small-cell lung cancer (NSCLC).